Market Overview
For the Quarter Ending September 2025
Famotidine Prices in North America
In United States, the Famotidine Price Index rose quarter-over-quarter in Q3 2025, driven by significant increases in production costs.
Famotidine production costs increased in Q3 2025, due to a 2.6 % year-over-year PPI rise in August 2025 and higher energy prices.
Demand for Famotidine faced mixed signals, with robust retail sales (5.42 % YoY in September 2025) offset by declining consumer confidence.
The Famotidine Price Index experienced upward pressure, reflecting a 3.0 % year-over-year CPI increase in September 2025 and rising input expenses.
Overall manufacturing activity contracted in Q3 2025, and broader economic conditions deteriorated, impacting the chemical market.
US natural gas prices strengthened year-over-year in Q3 2025, raising feedstock and wholesale power costs for chemical production.
Chemical inventories tightened in Q3 2025 due to accelerated destocking, while US chemical exports and imports decreased in July 2025.
A 4.3% unemployment rate in September 2025 supported consumer disposable income, positively influencing demand for healthcare products.
Why did the price of Famotidine change in September 2025 in North America?
Rising production costs, with a 2.6 % YoY PPI increase in August 2025, impacted Famotidine pricing.
Increased energy and raw material expenses, as US natural gas prices strengthened in Q3 2025, raised costs.
Mixed demand signals, including 5.42 % YoY retail sales in September 2025, influenced market.
Famotidine Prices in APAC
In China, the Famotidine Price Index fell quarter-over-quarter in Q3 2025, driven by declining production costs and elevated industry overcapacity.
Famotidine production costs decreased as the Producer Price Index declined 2.3% in September 2025 and international crude oil prices weakened.
Demand for Famotidine was supported by a 6.5 % rise in industrial production and 3.0 % growth in retail sales in September 2025.
However, the Manufacturing Index was contracting in September 2025, and consumer confidence was 89.6, tempering overall demand.
Industry overcapacity in the broader chemical sector remained elevated in Q3 2025, following significant capacity additions.
China's API market share expanded in Q3 2025, bolstered by government incentives and surging high-tech manufacturing output.
Healthcare spending strengthened in China in 2025, supported by increased government funding for public health services.
International crude oil prices gradually weakened in Q3 2025, reducing energy and feedstock costs for Famotidine production.
Why did the price of Famotidine change in September 2025 in APAC?
The Producer Price Index declined 2.3 % in September 2025, and international crude oil prices weakened, lowering production costs.
Elevated industry overcapacity and significantly increased chemical production capacity in Q3 2025 created downward price pressure.
A contracting Manufacturing Index in September 2025 and consumer confidence at 89.6 tempered demand, influencing prices.
Famotidine Prices in Europe
In Germany, Famotidine Price Index remained stable in Q3 2025, balancing demand and cost pressures.
Famotidine production costs saw downward pressure from a 1.7% decline in producer prices in September 2025.
Elevated energy and raw material costs, plus high carbon allowance costs, challenged Famotidine production in Q3 2025.
Famotidine demand outlook was supported by strengthening pharmaceutical demand and stable 0.2% retail sales in September 2025.
Consumer purchasing power for OTC Famotidine was impacted by a 2.4% CPI increase, despite stable 6.3% unemployment.
German industrial production declined 1.0% in September 2025, reflecting a contracting manufacturing index in Q3 2025.
European natural gas prices trended downwards through September 2025, though German prices inched up.
US tariffs significantly impacted German pharmaceutical exports in July 2025, affecting trade flows.
The Famotidine Price Index forecast suggests continued stability, influenced by ongoing demand and cost dynamics.
Why did the price of Famotidine change in September 2025 in Europe?
Strengthening pharmaceutical demand in Q3 2025 supported consumption, despite a 2.4% CPI increase.
Producer prices declined 1.7% in September 2025, but chemical energy and raw material costs remained elevated.
German industrial production fell 1.0% in September 2025; US tariffs impacted exports.
view historical insights
How We Can Help
ChemAnalyst: Your Source for Real-Time Market News, Weekly Price Updates
Stay ahead of the competition with ChemAnalyst, the premier provider of
actionable market news. We offer real-time updates on prices, tracking and
reporting pricing trends, market news, and demand & supply for over 450
commodities.
Why choose ChemAnalyst? We go beyond just providing prices - we give you the
insights behind them. Our expert analysts not only deliver accurate price
data but also explain the exact reasons why prices have gone up or down.
This knowledge helps you make informed decisions and understand market
dynamics.
Planning your purchase at the right timing is crucial, and that's why we
provide price forecasts. Our forecasts help you anticipate market movements,
enabling you to optimize your procurement strategy and maximize cost
savings. Additionally, we track plant shutdowns to assess any risks
associated with supply disruptions. By keeping you informed about potential
disruptions, we empower you to proactively manage your supply chain and
mitigate any potential issues.
Our Analysts team comprises chemical engineers and experts with strong
backgrounds in economics, manufacturing, supply chain, and trading. With
offices in Houston, Cologne, and New Delhi, we provide a comprehensive view
of the global market. Our ground teams are based out of more than 50+ major
trading ports such as Houston, Shanghai, Busan, Rotterdam, Jebel Ali,
Antwerp, Hamburg, and more. This ensures that we have firsthand information
and insights on market activities, allowing us to deliver accurate and
timely reports.
Don't miss out on valuable insights! Keep your procurement teams informed and
empowered with ChemAnalyst's unparalleled expertise.
Subscribe ChemAnalyst today for the latest market news and stay on top of
your game.
Product Description
Famotidine is a pharmaceutical compound belonging to the class of histamine H₂‑receptor antagonists. It is synthesized through multi‑step organic reactions involving heterocyclic intermediates, resulting in a crystalline solid with high purity suitable for medicinal use. Famotidine is typically formulated into tablets, oral suspensions, or injectable solutions, depending on therapeutic requirements.
The compound is characterized by its selective inhibition of histamine H₂ receptors in the stomach lining, effectively reducing gastric acid secretion. Famotidine exhibits favorable pharmacokinetic properties, including rapid absorption, reliable bioavailability, and a relatively long half‑life, which supports twice‑daily or once‑daily dosing. It is chemically stable under normal storage conditions and compatible with standard excipients used in pharmaceutical formulations.
Functionally, Famotidine is valued for its ability to relieve symptoms associated with excess stomach acid and promote healing of acid‑related conditions. Major application areas include the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, Zollinger‑Ellison syndrome, and prevention of stress‑induced gastric injury. Its efficacy, safety profile, and broad therapeutic utility make Famotidine a widely prescribed and trusted medication in gastrointestinal care.
